Novel SEQaBOO Study of Newborn Hearing Loss Foretells Role for Obstetricians in Genomic Medicine
As genetic and genomic sequencing become incorporated into newborn screening for hearing loss, patients may look to obstetricians for guidance on genetic testing decisions.
Auditory screening of newborns, mandated by most states in recent decades, now reaches an estimated 98 percent of newborns in the United States and has significantly reduced the average age for identifying congenital deafness. But adding genetic testing could drive more accurate diagnosis and personalized management during infancy’s critical window when the brain’s speech and language center is developing rapidly.
Read More